Enterprise tools aid compliance with the FDA rules on electronic signatures for benchtop microplate readers
Molecular Devices has announced the launch of SoftMax Pro Enterprise software, which provides tools necessary for Food and Drug Administration (FDA) 21 CFR Part 11 compliance, and is available for Molecular Devices's benchtop microplate readers.
SoftMax Pro, it says, continues to be the industry standard for its flexibility and robust data analysis capabilities critical to researchers in R and D, drug manufacturing, quality control and analysis in the biotech and pharmaceutical industries.
Commenting on the launch of SoftMax Pro Enterprise, Stephen Oldfield, vice president of marketing at Molecular Devices, noted: "We are pleased to be the only provider of CFR Part 11 compliance tools in the microplate reader market.
SoftMax Pro Enterprise will not only support our installed base of over 17,000 instruments, but we anticipate that the availability of SoftMax Pro Enterprise will stimulate new instrument sales for FDA 21 CFR-compliant applications." Since its introduction, SoftMax Pro has set the standard for data analysis software in the microplate reader industry and continues to be a major benefit of Molecular Devices' microplate readers.
SoftMax Pro Enterprise extends these capabilities by enabling site management through a centralised administrator, which provides electronic signature, full audit trails and other requirements needed for FDA 21 CFR Part 11 compliance.
SoftMax Pro Enterprise software works with Molecular Devices's benchtop readers, including SpectraMax absorbance readers, Gemini XS and Gemini EM fluorescence readers and FlexStation.
